Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 25 - 32 of 11409 results
2024 Pre-Election Analysis: Health Care Issues
August 26, 2024| Advisory| Viewpoint
The FTC’s Ban on Noncompetes Is No More. What Do Employers Do Now?
August 23, 2024| News
FTC Cracks Down on AI-Generated Fake Reviews – AI: The Washington Report
August 22, 2024| Article| Viewpoint
After Months of Uncertainty, a Federal Court Has Blocked the FTC’s Non-Compete Rule on a Nationwide Basis
August 21, 2024| Blog| Viewpoint
Tech Funding, IPOs Are Less Frequent in 2024
August 20, 2024| News
CMS 2026 IRA Price Negotiations Results Likely to Create Upstream and Downstream Effects
August 20, 2024| Blog| Viewpoint
News & Press Releases
Mintz DC Managing Member Michelle N. Lipkowitz Named a “Managing Partner of the Year” Finalist by The National Law Journal
September 09, 2024
Mintz announced that its DC office Managing Member Michelle N. Lipkowitz has been named a finalist for The National Law Journal’s inaugural “DC Managing Partner of the Year” award. The award recognizes “business leadership prowess” and highlights “notable initiatives and successes around law firm management,” according to the publication. The winner will be announced at an awards dinner on October 24.
Mintz Recognized in LMG’s “Life Sciences Americas Awards” 2024
September 06, 2024
Mintz received two awards at LMG’s 2024 “Life Sciences Americas Awards” which recognize the region’s “most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months.”
Understanding the Current State of M&A: Q&A with Cheryl Reicin
September 3, 2024
Member Cheryl Reicin participated in a Q&A with Pharmaceutical Executive focused how mergers and acquisitions are trending in the pharma industry.